VKH
ASMB icon

Virtu KCG Holdings’s Assembly Biosciences ASMB Stock Holding History

Virtu KCG Holdings’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-794
Closed -$60K – 3615
2014
Q1 		$60K Buy
794
+549
+224% +$85.5K ﹤0.01% 3304
2013
Q4 		$56K Buy
+245
New +$44.6K ﹤0.01% 3580

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu KCG Holdings's ASMB Position: Q2 2014 in Review

Virtu KCG Holdings sold out of Assembly Biosciences (ASMB) in Q2 2014, closing a stake of 794 shares — an estimated $60K sold.

Virtu KCG Holdings first reported a position in ASMB in Q4 2013 and held it in 2 quarters. The position peaked at $60K in Q1 2014. 27 funds tracked by Wall St. Rank hold ASMB as of Q2 2014.

  • Virtu KCG Holdings reported no remaining Assembly Biosciences position as of Q2 2014 after selling out during the quarter.
  • Virtu KCG Holdings sold 794 Assembly Biosciences shares in Q2 2014, an estimated $60K.
  • Virtu KCG Holdings first reported a position in Assembly Biosciences in Q4 2013 and held it in 2 quarters.
  • Virtu KCG Holdings's Assembly Biosciences position peaked at $60K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2014.

Based on Virtu KCG Holdings's 13F filing for Q2 2014, filed 14 Aug 2014.